Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.7657
+0.0037 (0.49%)
At close: Sep 11, 2025, 4:00 PM EDT
0.7601
-0.0056 (-0.73%)
After-hours: Sep 11, 2025, 5:11 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Injectable Biologics
9.29M
Log In
Log In
Log In
Log In
Upgrade
Injectable Biologics Growth
69.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
United States
9.29M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
69.16%
Log In
Log In
Log In
Log In
Upgrade